Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Otro Capital and its partner RedBird Capital in the transaction. Renault Group and Alpine announced a €200 million investment from Otro...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP advised New York-based investment company KKR & Co. Inc. (KKR) on its acquisition of Clinisupplies from Healthium. KKR was also advised...
You must be a Standard 1 Year member to access this content.
